RAER THERAPEUTICS LTD
Significant control: Nathan Mcnally (25–50%), Laura Anne Towart (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Raer Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Raer Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
RAER THERAPEUTICS LTD is an active private limited company (company number SC828508) incorporated on 11 November 2024, registered in Glasgow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 November 2025, showing net assets of £3 and cash of £3.
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Mr Nathan Mcnally
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Ms Laura Anne Towart
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Prof Ross Leigh Cagan
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr James Hadwin
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 11 November 20241 yr ago
- Next accounts due
- 30 August 2027in 310 days
- Confirmation statement due
- 25 November 2026in 32 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £3 | £3 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £3 at 30 November 2025
- Incorporated less than two years agoIncorporated 11 November 2024; no accounts due yet
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 310 days
- Confirmation statement duein 32 days
- Accounts period endNet assets £3 · dormant accounts
- Incorporated
Similar companies in Glasgow
- MYTEARS LIMITEDGlasgow · inc. Nov 2024
- FLASHSENS HEALTH LTDGlasgow · inc. Sept 2024
- TONRON INTERNATIONAL LIMITEDAirdrie · inc. Jan 2025
- BC BIOSCIENCES LTDGlasgow · inc. Mar 2025
- PALATTYS LTDGlasgow · inc. Jul 2024
- ENTOURAGE DIAGNOSTICS LTDGlasgow · inc. Apr 2025
All companies incorporated on 11 November 2024 · in Nov 2024.
Reminders for RAER THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.